Amr Makady

Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

Marc L. Berger, Harold C. Sox, Richard J. Willke et al. · Value in Health · 2017 · 452 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint <scp>ISPOR‐ISPE</scp> Special Task Force on real‐world evidence in health care decision making

Marc L. Berger, Harold C. Sox, Richard J. Willke et al. · Pharmacoepidemiology and Drug Safety · 2017 · 344 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies

Amr Makady, Ard van Veelen, Páll Jónsson et al. · PharmacoEconomics · 2017 · 105 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +16

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

Shirley Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiß et al. · Nature Communications · 2022 · 102 citations · Full text

Pharmacy, Pharmacoeconomics, Evidence-based Practice +15

Implementing managed entry agreements in practice: The Dutch reality check

Amr Makady, Ard van Veelen, Anthonius de Boer et al. · Health Policy · 2018 · 59 citations · Full text

Management, Business Law, Institutional Theory +4